New coronal pneumonia rehabilitation method after cure based on intermittent high-low oxygen cardiopulmonary therapy system

Abstract

The invention relates to a new coronal pneumonia rehabilitation method after cure based on an intermittent high-low oxygen cardiopulmonary therapy system. The new coronal pneumonia rehabilitation method after cure comprises the following steps of establishing a physiological database, collecting first physiological data of a patient, and setting a physiological data ratio balance range; carrying out low-oxygen respiratory treatment, collecting second physiological data of the patient in real time, calculating a real-time physiological data ratio, stopping low-oxygen respiratory treatment and carrying out high-oxygen respiratory treatment if the real-time physiological data ratio exceeds or is lower than the physiological data balance ratio, and stopping high-oxygen respiratory treatment when the real-time physiological data ratio is recovered to an initial state; and performing high-low oxygen respiratory treatment for multiple times, generating multiple groups of first low-oxygen respiratory treatment parameters and first high-oxygen respiratory treatment parameters, and generating a high-low oxygen rehabilitation scheme after cure suitable for the patient, wherein the physiological data is the content of angiotensin converting enzyme and angiotensin converting enzyme 2 of the patient. By adopting the scheme, the patient can be subjected to rehabilitation treatment after new coronal pneumonia is cured, the lung function is improved, and the respiratory function is improved.

Description

technical field [0001] The present invention relates to the medical field, and more specifically, relates to a post-cure rehabilitation method for new coronary pneumonia based on an intermittent high-low oxygen cardiopulmonary therapy system. Background technique [0002] The new coronavirus infects cells through angiotensin-converting enzyme 2 (ACE2). During virus infection, angiotensin-converting enzyme 2 (ACE2) is the membrane-bound receptor of the new coronavirus, which is related to the fusion and invasion process of the virus and host cells, that is, angiotensin-converting enzyme 2 (ACE2) is the new coronavirus Necessary targets for viruses to infect humans. When the new coronavirus enters the human body, it invades lung cells through the combination of S protein and angiotensin-converting enzyme 2 (ACE2), and down-regulates the level of angiotensin-converting enzyme 2 (ACE2), resulting in angiotensin-converting enzyme 2 (ACE2) in the lungs. ) and angiotensin-convert...

AI Technical Summary

Problems solved by technology

[0004] However, there are currently few ways to improve the lung function and rehabilitation of cured patients with new coronary pneumonia, resulting in o...

Images